Search by Drug Name or NDC

    NDC 68180-0718-12 Doxercalciferol 4 ug/2mL Details

    Doxercalciferol 4 ug/2mL

    Doxercalciferol is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is DOXERCALCIFEROL.

    Product Information

    NDC 68180-0718
    Product ID 68180-718_aebb9485-72fe-4b2d-85af-913f29954bfe
    Associated GPIs 30905040002020
    GCN Sequence Number 064864
    GCN Sequence Number Description doxercalciferol VIAL 4MCG/2ML INTRAVEN
    HIC3 P4D
    HIC3 Description HYPERPARATHYROID TX AGENTS - VITAMIN D ANALOG-TYPE
    GCN 16897
    HICL Sequence Number 020533
    HICL Sequence Number Description DOXERCALCIFEROL
    Brand/Generic Generic
    Proprietary Name Doxercalciferol
    Proprietary Name Suffix n/a
    Non-Proprietary Name Doxercalciferol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 4
    Active Ingredient Units ug/2mL
    Substance Name DOXERCALCIFEROL
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Ergocalciferols [CS], Vitamin D2 Analog [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210801
    Listing Certified Through 2024-12-31

    Package

    NDC 68180-0718-12 (68180071812)

    NDC Package Code 68180-718-12
    Billing NDC 68180071812
    Package 10 VIAL, MULTI-DOSE in 1 CARTON (68180-718-12) / 2 mL in 1 VIAL, MULTI-DOSE (68180-718-01)
    Marketing Start Date 2019-12-17
    NDC Exclude Flag N
    Pricing Information N/A